Merrimack Pharmaceuticals
(NASDAQ:MACK)
$14.75
0[0.00%]
At close: Mar 28
$14.75
0[0.00%]
After Hours: 7:43PM EDT
25%
Overview Rating
Speculative
Technicals Analysis
66
0100
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
0
0
0
0
Feb
0
0
0
0
Jan
0
0
0
0
Dec 23
0
0
0
0
Nov 23
0
0
0
0
Oct 23
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
-
No Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
About Merrimack Pharmaceuticals Inc
Sector
Health Care
Industry
Biotechnology
Merrimack Pharmaceuticals Inc is a biotechnology company that discovers, develops, and commercialize...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
MACK
OTLK

FAQ

Q

How do I buy Merrimack Pharmaceuticals (MACK) stock?

A

You can purchase shares of Merrimack Pharmaceuticals (NASDAQ: MACK) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Merrimack Pharmaceuticals's (MACK) competitors?

Q

What is the target price for Merrimack Pharmaceuticals (MACK) stock?

A

The latest price target for Merrimack Pharmaceuticals (NASDAQ: MACK) was reported by Baird on Monday, October 22, 2018. The analyst firm set a price target for 4.00 expecting MACK to fall to within 12 months (a possible -72.88% downside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Merrimack Pharmaceuticals (MACK)?

A

The stock price for Merrimack Pharmaceuticals (NASDAQ: MACK) is $14.75 last updated March 28, 2024 at 7:43 PM EDT.

Q

Does Merrimack Pharmaceuticals (MACK) pay a dividend?

A

A quarterly cash dividend of $0.50 per share of Class A Common Stock. The quarterly cash dividend was payable on December 23, 2019 to stockholders of record on December 13, 2019.

Q

When is Merrimack Pharmaceuticals (NASDAQ:MACK) reporting earnings?

A

Merrimack Pharmaceuticals’s Q4 earnings are confirmed for Wednesday, March 8, 2023.

Q

Is Merrimack Pharmaceuticals (MACK) going to split?

A

There is no upcoming split for Merrimack Pharmaceuticals.

Q

What sector and industry does Merrimack Pharmaceuticals (MACK) operate in?

A

Merrimack Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch